Impact News +++ Aktien der Woche: Moderna-Aktie explodiert, Walmart bricht ein (Investing.com DE) +++ MODERNA Aktie -3,75%

ILLUMINA Aktie

>ILLUMINA Aktienkurs

187.74 EUR +2.8% (TradegateBSX)

Ask: 188.06 EUR / 160 Stück

Bid: 187.76 EUR / 160 Stück

Tagesumsatz: 700 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

ILLUMINA Aktie über LYNX handeln

Intraday

1 Jahr

>ILLUMINA Performance

1 Woche: +13,6%

1 Monat: +10,9%

3 Monate: +51,6%

6 Monate: +88,3%

1 Jahr: +116,6%

laufendes Jahr: +64,3%

>ILLUMINA Aktie

Profil:

Illumina, Inc. is a life sciences and diagnostics company that develops, manufactures, and markets tools and integrated systems for the analysis of genetic material. Its primary focus is on next-generation sequencing technologies, providing high-thro..
>Volltext..

Insiderhandel:

>ILLUMINA Kennzahlen

Aktien/ Unternehmen:

Analysten:

Bewertung:

Rentabilität:

Managementeffizenz:

>ILLUMINA Peer Group

Gesundheit, Medizinprodukte & -technik/ Implantate/ Wundpflege, Infektionskrankheiten/ Impfstoffentwicklung/ Antibiotika, Onkologie/ Krebs- Behandlung, Zell- & Gentherapie/ Gentechnik/ Erbkrankheiten

>ILLUMINA Chart & Kurs - NASDAQ

>ILLUMINA News

22.08.26 - 05:01	Insiderhandel: Aufsichtsrat verkauft Aktien von Illumina im Wert von 61000126 USD (Insiderkauf)
	Meister, Keith A. - Aufsichtsrat - Tag der Transaktion: 2026-08-20...

22.08.26 - 05:01	Insiderhandel: Aufsichtsrat verkauft Aktien von Illumina im Wert von 19312826 USD (Insiderkauf)
	Meister, Keith A. - Aufsichtsrat - Tag der Transaktion: 2026-08-19...

22.08.26 - 05:01	Insiderhandel: Aufsichtsrat verkauft Aktien von Illumina im Wert von 65243447 USD (Insiderkauf)
	Meister, Keith A. - Aufsichtsrat - Tag der Transaktion: 2026-08-21...

21.08.26 - 19:24	AKTIONÄR-Tipp Illumina: Totgesagte leben länger – Turnaround nimmt dank Moderna Fahrt auf (Der Aktionaer)
	Hinter dem Genom-Sequenzierungsspezialisten Illumina liegen schwierige Jahre. Wachsender Konkurrenzdruck und das Hin und Her rund um den Flüssigbiopsie-Player GRAIL haben die Aktie von gut 480 Dollar im Jahr 2021 auf zeitweise unter 80 Dollar einbrechen lassen....

21.08.26 - 01:01	Insiderhandel: SVP, Strategy/Corp Development verkauft Aktien von Illumina im Wert von 197840 USD (Insiderkauf)
	Wedel, Christensen Jakob - Vorstand - Tag der Transaktion: 2026-08-18...

20.08.26 - 15:06	Girard Sharp LLP and The Hall Firm, Ltd. Announces Notice of Class Action For All Persons or Entities Who Acquired Illumina Common Stock in Exchange for GRAIL Securities in the August 18, 2021 Merger Between Illumina and GRAIL (PR Newswire)
	SAN FRANCISCO, Aug. 20, 2026 /PRNewswire/ -- SUMMARY NOTICE OF CLASS ACTION SUPERIOR COURT OF THE STATE OF CALIFORNIA, COUNTY OF SAN MATEO TO: ALL PERSONS OR ENTITIES WHO ACQUIRED ILLUMINA, INC. ("ILLUMINA") COMMON STOCK IN EXCHANGE FOR GRAIL, INC. ("GRAIL") SECURITIES IN THE AUGUST 18,......

07.08.26 - 19:45	What Makes Illumina (ILMN) a New Strong Buy Stock (Zacks)
	Illumina (ILMN) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term....

07.08.26 - 01:01	Insiderhandel: Aufsichtsrat verkauft Aktien von Illumina im Wert von 91616565 USD (Insiderkauf)
	Meister, Keith A. - Aufsichtsrat - Tag der Transaktion: 2026-08-04...

07.08.26 - 01:01	Insiderhandel: Aufsichtsrat verkauft Aktien von Illumina im Wert von 56543332 USD (Insiderkauf)
	Meister, Keith A. - Aufsichtsrat - Tag der Transaktion: 2026-08-05...

04.08.26 - 02:24	Illumina (ILMN) Q2 2026 Earnings Call Transcript (Fool)
	Clinical momentum and NovaSeq X placements drive revenue guidance raise....

03.08.26 - 23:01	Insiderhandel: Chief Legal Officer verkauft Aktien von Illumina im Wert von 123000 USD (Insiderkauf)
	Davies, Scott M. - Vorstand - Tag der Transaktion: 2026-07-30...

01.08.26 - 00:30

US Stocks Rally To End Turbulent Month | The Close 7/31/2026 (Bloomberg)

Bloomberg Television brings you the latest news and analysis leading up to the final minutes and seconds before and after the closing bell on Wall Street. Today's guests are UBS Head of US Rates Strategy Phoebe White, Glide Identity Founder & CEO Eran Haggiag & Verizon Business Senior VP, Chief Product Officer Scott Lawrence, Rosenblatt Securities Senior Research Analyst & Managing Director Barton Crockett, Chevron CFO Eimear Bonner, Wells Fargo Investment Institute Global Asset Allocation Strategist Veronica Willis, First Founder & CEO Libby Leffler, Illumina CEO Jacob Thaysen, Most Valuable Promotions Co-Founders Jake Paul & Nakisa Bidarian, & Most Valuable Promotions CEO & Board Member John Martin, & Serhant CEO & Founder Ryan Serhant. (Source: Bloomberg)...

31.07.26 - 22:54	Illumina CEO on Genomic Sequencing Opportunities and AI (Bloomberg)
	Illumina CEO Jacob Thaysen discusses the company's earnings, genomic medicine opportunities and the potential for artificial intelligence in life sciences on "Bloomberg The Close." (Source: Bloomberg)...

31.07.26 - 04:00	Illumina (ILMN) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
	The headline numbers for Illumina (ILMN) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals....

31.07.26 - 03:48	Illumina (ILMN) Q2 2026 Earnings Call Transcript (Fool)
	Clinical momentum and NovaSeq X placements drive revenue guidance raise....

31.07.26 - 01:45	Illumina (ILMN) Tops Q2 Earnings and Revenue Estimates (Zacks)
	Illumina (ILMN) delivered earnings and revenue surprises of +6.50% and +3.36%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?...

30.07.26 - 22:54	Illumina Inc. Profit Retreats In Q2 (AFX)
	SAN DIEGO (dpa-AFX) - Illumina Inc. (ILMN) revealed earnings for second quarter that Drops, from the same period last yearThe company's earnings came in at $207 million, or $1.35 per share. This c......

30.07.26 - 22:12	Illumina Non-GAAP EPS of $1.31 beats by $0.08, revenue of $1.16B beats by $30M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

30.07.26 - 22:09	Illumina Reports Financial Results for Second Quarter of Fiscal Year 2026 (PR Newswire)
	SAN DIEGO, July 30, 2026 /PRNewswire/ -- Illumina, Inc. (Nasdaq: ILMN) ("Illumina" or the "company") today announced its financial results for the second quarter of fiscal year 2026. Second quarter 2026 results Revenue of $1.16 billion for Q2 2026, up 9.5% from Q2 2025 and up 8.1%......

28.07.26 - 14:03	Standard BioTools Announces Sale of Mass Cytometry Business and Illumina′s Buyout of Contingent Payments to Advance Merger with Treeline Biosciences (GlobeNewswire EN)
	Sale of Mass Cytometry Business to Multiplex Bio Ensures Full Continuity of CyTOF and Hyperion Product Lines, Customer Relationships, Dedicated Team and Continued Investment in Next Generation Multiplex Platforms...

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Werde nie so reich an Geist, dass arm Du würdest am Herzen! - Otto Ludwig

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram